Westminster Homecare has been acquired by Care at Home
The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.
Westminster Homecare is a specialist provider of care services to the elderly and young adults. It operates a network of branches throughout London and the South of England delivering care services to over 3,500 service users, enabling them to remain independent in their homes for longer.
Care at Home is a privately owned, independent family business providing a range of care services to clients in their own homes, under several brands including Care at Home Services, Beech Tree Total Care, Domus Live-In Care, and now Westminster Homecare. Care at Home partnered with ThinCats, an alternative lender that provides loans to mid-sized UK businesses, to help fund the transaction.
Oaklins Evelyn Partners, based in the UK, worked with the shareholders of Westminster Homecare to deliver a successful sale to a strategic partner. Combined, the group will be one of the largest providers of homecare services, with over 3,700 staff operating from 28 branches delivering homecare to the community and also care in 18 extra care facilities.
Sushil Radia
CEO, Westminster Homecare Ltd.
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more